Effect of suplatast tosilate, a Th2 cytokine inhibitor, on cough variant asthma

No abstract is available for this paper.

• Publication year

  2002

• Venue

  European Journal of Clinical Pharmacology

• Publication date

  2002-05-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00228-002-0468-zPMID 12107601
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New anti-asthma therapies: suppression of the effect of interleukin (IL)-4 and IL-5.

  2001cited by this paper
• Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study. Tokyo Joshi-Idai Asthma Research Group.

  2000cited by this paper
• T Cells and Chronic Asthma

  1999cited by this paper
• Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians.

  1998cited by this paper
• Eosinophilic inflammation in cough variant asthma.

  1998cited by this paper
• Anti-inflammatory effect of suplatast tosilate on mild asthma.

  1997cited by this paper
• Cough threshold for capsaicin increases by azelastine in patients with cough-variant asthma.

  1996cited by this paper
• Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model

  1996cited by this paper
• Neurophysiology of the cough reflex.

  1995cited by this paper
• Down-regulation of Th2 cell-mediated murine peritoneal eosinophilia by antiallergic agents.

  1995cited by this paper
• Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody.

  1995cited by this paper
• Interleukin-4 is required for the induction of lung Th2 mucosal immunity.

  1995cited by this paper
• Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice.

  1995cited by this paper
• Cough receptor sensitivity and bronchial responsiveness in patients with only chronic nonproductive cough: in view of effect of bronchodilator therapy.

  1994cited by this paper
• Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsulfonium agent: (2). Regulation of human IgE response.

  1994cited by this paper
• Serum measurements of eosinophil cationic protein (ECP) in bronchial asthma

  1993cited by this paper
• Cough receptor sensitivity and bronchial responsiveness in normal and asthmatic subjects.

  1992cited by this paper
• Capsaicin-induced cough in humans.

  1992cited by this paper
• IPD-1151T: a prototype drug for IgE antibody synthesis modulation.

  1992cited by this paper
• Capsaicin-induced Cough in Humans 1 • 2

  1992cited by this paper
• Direct-writing recorder of the dose-response curves of the airway to methacholine. Clinical application.

  1981cited by this paper
• Chronic cough as the sole presenting manifestation of bronchial asthma.

  1979cited by this paper
• Variant asthma.

  1972cited by this paper
• Physicians

  1964cited by this paper

• Successful Treatment of a Case of Hypereosinophilia with Suplatast Tosilate Monotherapy

  2024cites this paper
• Suplatast tosilate reduces peripheral blood eosinophil levels in patients with eosinophilia: a real-world retrospective study

  2024cites this paper
• Formononetin isolated from Sophorae flavescentis inhibits B cell-IgE production by regulating ER-stress transcription factor XBP-1

  2023cites this paper
• Efficacy and Safety of Yukmijihwang-Tang in the Treatment of Cough-Variant Asthma: Study Protocol for a Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial

  2023cites this paper
• Inhibition of suplatast tosilate on EPSC in the single paratracheal ganglion neurons attached with presynaptic boutons.

  2023cites this paper
• The TLR4/NF-κB signaling pathway-mediated type 2 skewing of T helper cell in cough variant asthma was counteracted by ethanol extract of Anacyclus pyrethrum root.

  2023cites this paper
• Objective and Subjective Measurement of Cough in Asthma: A Systematic Review of the Literature

  2022cites this paper
• Retrospective Study of the Effects of Post-nasal Drip Symptoms on Cough Duration

  2021cites this paper
• Direct Potentiation of Capsaicin Current by Histamine and Its Effect by Suplatast on Rat Trigeminal Ganglia Neurons

  2018cites this paper
• Heptamethoxyflavone Reduces Phosphodiesterase Activity and T-Cell Growth in vitro

  2017cites this paper
• The effects of suplatast tosilate on acutely dissociated sensory and paratracheal ganglia neurons.

  2016cites this paper
• Effects of regular treatment with combination of salmeterol/fluticasone propionate and salmeterol alone in cough variant asthma

  2015cites this paper
• Novel Antitussive Effect of Suplatast Tosilate in Guinea Pigs

  2015cites this paper
• Eosinophilic Bronchial Disorders Presenting Chronic Cough; Atopic Cough, Cough Variant Asthma and Non-Asthmatic Eosinophilic Bronchitis

  2014cites this paper
• Recent research and developmental strategy of anti-asthma drugs.

  2012cites this paper
• Review: Effect of drugs on human cough reflex sensitivity to inhaled capsaicin

  2012cites this paper
• Comparable effect of a leukotriene receptor antagonist and long-acting beta₂-adrenergic agonist in cough variant asthma.

  2010cites this paper
• Pharmacological and non-pharmacological interventions for cough in adults with respiratory and non-respiratory diseases: A systematic review of the literature.

  2010cites this paper
• A Case of Eosinophilic Pneumonia Successfully Treated with Suplatast Tosilate Alone

  2009cites this paper
• Usefulness of suplatast tosilate for chronic cough following lung cancer surgery

  2009cites this paper
• [Lower airway nervous system as a putative target of antitussive drugs effective for treatment of chronic cough].

  2008cites this paper
• Effect of an Orally Active Th2 Cytokine Inhibitor, Suplatast Tosilate, on “Atopic Cough”

  2008cites this paper
• Progress in suplatast tosilate research

  2007cites this paper
• Pharmacotherapy of cough-variant asthma

  2007cites this paper
• Treatment of cough

  2006cites this paper
• Prolonged and chronic cough

  2006cites this paper
• Chronic cough due to asthma: ACCP evidence-based clinical practice guidelines.

  2006cites this paper
• Safety of capsaicin cough challenge testing.

  2005cites this paper
• Identifying Predictors of Response to Suplatast Tosilate among Patients with Moderate to Severe Bronchial Asthma Receiving Inhaled Steroid Therapy

  2005cites this paper
• Cough and Gender

  2005cites this paper
• Effect of inhaled corticosteroids on symptom severity and sputum mediator levels in chronic persistent cough.

  2004cites this paper
• CD28 and secretory immunoglobulin A‐dependent activation of eosinophils: inhibition of mediator release by the anti‐allergic drug, suplatast tosilate

  2004cites this paper
• Effectiveness of montelukast in the treatment of cough variant asthma.

  2004cites this paper
• Rationale for new treatments aimed at IgE immunomodulation.

  2004cites this paper
• Role of a Th2 cytokine inhibitor in asthma treatment

  2004cites this paper
• A Preliminary Study of PEFR Monitoring in Patients with Chronic Cough

  2004cites this paper
• New strategies in the treatment and prevention of allergic diseases

  2004cites this paper
• Rationale for new treatments aimed at IgE

  2004cites this paper
• COMPUTATIONAL DRUG DOCKING TO IDENTIFY POSSIBLE THERAPEUTICS THAT WARRANT FURTHER INVESTIGATION FOR ZOONOTIC DISEASES

  year unknowncites this paper